Alterations of the Tissue Inhibitor of Metalloproteinase-3 (TIMP3) Gene in Pancreatic Adenocarcinomas

Pancreas

Volumn 30, Issue 2, 2005, Pages

  Fendrich, Volker ^a   Slater, Emily P ^a   Heinmöller, Ernst ^b   Ramaswamy, Annette ^a   Celik, Ilhan ^a   Nowak, Oxana ^a   Chaloupka, Brunhilde ^a   Gerdes, Berthold ^a   Bartsch, Detlef K ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b KLINIKUM KASSEL   (Germany)

Author keywords

Methylation; Pancreatic carcinomas; TIMP3; Tumor suppressor gene

Indexed keywords

TIMP3 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ADENOCARCINOMA; AGED; ARTICLE; DNA METHYLATION; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PANCREAS; PANCREAS TUMOR; PATHOLOGY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 33444456007     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/01.mpa.0000153325.62192.8a     Document Type: Article

References (28)

1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7-33.
2. Goggins M, Canto M, Hruban R. Can we screen high-risk individuals to detect early pancreatic carcinoma? J Surg Oncol. 2000;74:243-248.
3. Rozenblum E, Schutte M, Goggins M, et al. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res. 1997;57:1731-1734.
4. Bartsch D, Shevlin DW, Tung WS, et al. Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas genes. Chromosomes Cancer. 1995;14:189-195.
5. Bartsch D, Shevlin DW, Callery MP, et al. Reduced survival in patients with ductal pancreatic adenocarcinoma associated with CDKN2 mutation. J Natl Cancer Inst. 1996;88:680-682.
6. Gerdes B, Ramaswamy A, Ziegler A, et al. p16INK4a is a prognostic marker in resected ductal pancreatic cancer: an analysis of p16INK4a, p53, MDM2, and Rb. Ann Surg. 2002;235:51-59.
7. Gomez DE, Alonso DF, Yoshiji H, et al. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol. 1997;74:111-122.
8. Anand-Apte B, Bao L, Smith R, et al. A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochem Cell Biol. 1996;74:853-862.
9. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 1997;89:1260-1270.
10. Ahonen M, Baker AH, Kahari VM. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res. 1998;58:2310-2315.
11. Baker AH, George SJ, Zaltsman AB, et al. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br J Cancer. 1999;79:1347-1355.
12. Bachman KE, Herman JG, Corn PG, et al. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res. 1999;59:798-802.
13. Wild A, Ramaswamy A, Langer P, et al. Frequent methylation associated silencing of the tissue inhibitor of metalloproteinase-3 (TIMP-3) gene in pancreatic endocrine tumors. J Clin Endocrinol Metab. 2003;88:1367-1373.
14. Ueki T, Toyota M, Sohn T, et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res. 2000;60:1835-1839.
15. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996;93:9821-9826.
16. Heinmöller E, Dietmaier W, Zirngibl H, et al. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol. 2000;157:83-92.
17. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 1997;89:1260-1270.
18. Anand-Apte B, Pepper MS, Voest E, et al. Inhibition of angiogenesis by tissue inhibitor of metalloproteinases-3. Invest Ophthalmol Vis Sci. 1997;38:817-823.
19. Bian J, Wang Y, Smith MR, et al. Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP-3). Carcinogenesis. 1996;17:1805-1811.
20. Lee S, Kim WH, Jung HY, et al. Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma. Am J Pathol. 2002;161:1015-1022.
21. Wild A, Langer P, Ramaswamy A, et al. A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications. J Clin Endocrinol Metab. 2001;86:5782-5787.
22. Wild A, Langer P, Celik I, et al. Chromosome 22q in pancreatic endocrine tumors: identification of a homozygous deletion and potential prognostic associations of allelic deletions. Eur J Endocrinol. 2002;147:1-7.
23. Jones LE, Humphreys MJ, Campbell F, et al. Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinases-7 predicts poor survival. Clin Cancer Res. 2004;10:2832-2845.
24. Felbor U, Su Vanto EA, Forsius HR, et al. Autosomal recessive Sorsby fundus dystrophy revisited: molecular evidence for dominant inheritance. Am J Hum Genet. 1997;60:57-62.
25. Ayyagari R, Griesinger IB, Bingham E, et al. Autosomal dominant hemorrhagic macular dystrophy not associated with the TIMP3 gene. Arch Ophthalmol. 2000;118:85-92.
26. Zöchbauer-Müller S, Fong KM, Virmani Akgeradts J, et al. Aberrant promoter hypermethylation of multiple genes in non-small cell lung cancers. Cancer Res. 2001;61:249-255.
27. Hruban RH, van Mansfeld A, Offerhaus G. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol. 1993;143:545-554.
28. Sessa F, Bonato M, Bisoni D, et al. Ki-ras and p53 gene mutations in pancreatic ductal carcinoma: a relationship with tumor phenotype and survival. Eur J Histochem. 1998;42:67-76.